Inventor · disambiguated record
Stephen Coutts
Also filed as: COUTTS STEPHEN · COUTTS STEPHEN M
22 granted patents·6 pending applications·1,059 citations·filing 1983–2023
97Inventor score
Top patents by PatentIndex Score
28 records- 0197US5552391AChemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 1993·Granted Sep 3, 1996·160 cites·12 claims
- 0292US7430849B1Conveyor chain pin removerPRACTICAL INV S LLC·Filed 2008·Granted Oct 7, 2008·378 cites·7 claims
- 0390US7351855B2Chemically defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 2003·Granted Apr 1, 2008·24 cites·143 claims
- 0489US5606047AChemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 1995·Granted Feb 25, 1997·65 cites·1 claims
- 0589US5276013AConjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosusJOLLA PHARMA·Filed 1992·Granted Jan 4, 1994·59 cites·33 claims
- 0689US4579866APhenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agentsUSV PHARMA CORP·Filed 1984·Granted Apr 1, 1986·39 cites·7 claims
- 0785US6060056AComposition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform moleculeJOLLA PHARMA·Filed 1993·Granted May 9, 2000·58 cites·56 claims
- 0884US4477446A1-Benzazepines and their pharmaceutical usesUSV PHARMA CORP·Filed 1983·Granted Oct 16, 1984·14 cites·15 claims
- 0983US5726329AModified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotidesJOLLA PHARMA·Filed 1995·Granted Mar 10, 1998·53 cites·11 claims
- 1083US5162515AConjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosusJOLLA PHARMA·Filed 1990·Granted Nov 10, 1992·40 cites·2 claims
- 1182US8720324B2Stovetop grilling deviceCOUTTS STEPHEN·Filed 2012·Granted May 13, 2014·8 cites·28 claims
- 1281US7836619B2Inflatable flag displayCOUTTS STEPHEN·Filed 2008·Granted Nov 23, 2010·6 cites·12 claims
- 1380US5633395AChemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 1995·Granted May 27, 1997·33 cites·1 claims
- 1479US8151699B2Stovetop grilling deviceCOUTTS STEPHEN·Filed 2009·Granted Apr 10, 2012·9 cites·40 claims
- 1577US5391785AIntermediates for providing functional groups on the 5' end of oligonucleotidesJOLLA PHARMACEUTIAL COMPANY·Filed 1992·Granted Feb 21, 1995·32 cites·6 claims
- 1677US4956371ASubstituted isoquinolines and methods of using sameEURO CELTIQUE SA·Filed 1989·Granted Sep 11, 1990·20 cites·17 claims
- 1776US5874552AModified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotidesJOLLA PHARMA·Filed 1995·Granted Feb 23, 1999·29 cites·18 claims
- 1874US9049955B2Smokeless stovetop grilling deviceCOUTTS STEPHEN·Filed 2012·Granted Jun 9, 2015·4 cites·23 claims
- 1974US5786512AModified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotidesLAJOLLA PHARMACEUTICAL COMPANY·Filed 1994·Granted Jul 28, 1998·24 cites·2 claims
- 2070US7115581B2Chemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 2002·Granted Oct 3, 2006·1 cites·46 claims
- 2164US2008293660A1Chemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 2008·Application pending·0 cites
- 2262US2025059153A1Bicyclic quinones, pharmaceutical compositions, and therapeutic applicationsIC MEDTECH CORP·Filed 2023·Application pending·0 cites
- 2360US2007254851A1Chemically-defined non-polymeric valency platform molecules and conjugates thereofCOUTTS STEPHEN M·Filed 2006·Application pending·0 cites
- 2456US2002082400A1Conjugates of T cell epitope deficient immunogen analogs for humoral anergy and chemically defined non-polymeric valency platform moleculesFiled 2000·Application pending·0 cites
- 2556US2002107389A1Conjugates of chemically defined non-polymeric valency platform molecules and biologically active moleculesFiled 2000·Application pending·0 cites
- 2646US2021283100A1Ascorbic acid, quinone compound, and sodium glucose cotransporter inhibitor for treating cancerIC MEDTECH CORP·Filed 2017·Application pending·0 cites
- 2740US5019573ASubstituted dibenzofurans and methods of using sameEURO CELTIQUE SA·Filed 1989·Granted May 28, 1991·3 cites·23 claims
- 2829USRE34630ESubstituted isoquinolines and methods of using sameEURO CELTIQUE SA·Filed 1992·Granted Jun 7, 1994·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →